“…The prevalence of ITP in lymphoma studies was 0/92 in myeloma, 8 4% in MZL (54), 1.2% in follicular lymphomas (our department), 3.8-10% in makroglobulinemia, 10,28,55 and 9% in mantle cell lymphoma. 56 In T-cell lymphomas a prevalence of 11.1% 57 and in AILD prevalence of 24% 58,59 of thrombocytopenias was reported, but pathogenesis was not determined (Table 2 and 3).…”